Evidence map›Paper›PMID 28753763›Full record

ArticleEuropean urology focus2017

Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.

George Lee, Robert W Veltri, Guangjing Zhu, Sahirzeeshan Ali, Jonathan I Epstein, Anant Madabhushi

Abstract read
In one paragraph

Article in European urology focus, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

George LeeDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA. Electronic address: george.lee@case.edu.
Robert W VeltriDepartment of Urology, James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Guangjing ZhuDepartment of Urology, James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sahirzeeshan AliDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
Jonathan I EpsteinDepartment of Urology, James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Anant MadabhushiDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA. Electronic address: anant.madabhushi@case.edu.
Case Western Reserve University · USJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Software to facilitate multimode, multiscale fused data for Pathology and RadioloR01CA136535 · NCI · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, MICHAEL D, MADABHUSHI, ANANT · 2009 to 2013
$3.2M
Prostate-cancer Imaging by Combined Ultrasound and Magnetic-resonance ParametersR01CA140772 · NCI · RIVERSIDE RESEARCH INSTITUTE · PI FELEPPA, ERNEST JOSEPH · 2010 to 2014
$3.0M
Comprehensive quantitative ultrafast 3D liver MRIR01DK098503 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI GULANI, VIKAS, SEIBERLICH, NICOLE · 2013 to 2017
$2.6M
Decision support with MRI for targeting, evaluating laser ablation for prostate cR21CA167811 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI MADABHUSHI, ANANT · 2012 to 2013
$516k
Histologic image-based aggressiveness prediction in p16+ oropharyngeal carcinomaR21CA179327 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MADABHUSHI, ANANT · 2014 to 2015
$389k
Big data convergence of pathology and omics for disease prognosisK01ES026841 · NIEHS · CASE WESTERN RESERVE UNIVERSITY · PI LEE, GEORGE · 2015 to 2015
$81k
NCI NIH HHS R01 CA136535NCI NIH HHS R01 CA140772NCI NIH HHS R21 CA167811NCI NIH HHS R21 CA179327NIDDK NIH HHS R01 DK098503NIEHS NIH HHS K01 ES026841
6 · The paper itself

Abstract

backgroundGleason scoring represents the standard for diagnosis of prostate cancer (PCa) and assessment of prognosis following radical prostatectomy (RP), but it does not account for patterns in neighboring normal-appearing benign fields that may be predictive of disease recurrence.

objectiveTo investigate (1) whether computer-extracted image features within tumor-adjacent benign regions on digital pathology images could predict recurrence in PCa patients after surgery and (2) whether a tumor plus adjacent benign signature (TABS) could better predict recurrence compared with Gleason score or features from benign or cancerous regions alone. DESIGN, SETTING, AND

participantsWe studied 140 tissue microarray cores (0.6mm each) from 70 PCa patients following surgery between 2000 and 2004 with up to 14 yr of follow-up. Overall, 22 patients experienced recurrence (biochemical [prostate-specific antigen], local, or distant recurrence and cancer death) and 48 did not.

interventionRP was performed in all patients. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The top 10 features identified as most predictive of recurrence within both the benign and cancerous regions were combined into a 10-feature signature (TABS). Computer-extracted nuclear shape and architectural features from cancerous regions, adjacent benign fields, and TABS were evaluated via random forest classification accuracy and Kaplan-Meier survival analysis. RESULTS AND LIMITATIONS: Tumor-adjacent benign field features were predictive of recurrence (area under the receiver operating characteristic curve [AUC]: 0.72). Tumor-field nuclear shape descriptors and benign-field local nuclear arrangement were the predominant features found for TABS (AUC: 0.77). Combining TABS with Gleason sum further improved identification of recurrence (AUC: 0.81). All experiments were performed using threefold cross-validation without independent test set validation.

conclusionsComputer-extracted nuclear features within cancerous and benign regions predict recurrence following RP. Furthermore, TABS was shown to provide added value to common predictors including Gleason sum and Kattan and Stephenson nomograms. PATIENT SUMMARY: Future studies may benefit from evaluation of benign regions proximal to the tumor on surgically excised prostate cancer tissue for assessing risk of disease recurrence.

Indexed as

AgedBiomarkers, TumorCell NucleusDiagnosis, Computer-AssistedHumansMaleMiddle AgedNeoplasm GradingNeoplasm Recurrence, LocalPredictive Value of TestsPrognosisProstatectomyProstate-Specific AntigenProstatic NeoplasmsBiomarkers, TumorProstate-Specific AntigenDigital pathologyField effectMarkersPrognosisProstate cancerQuantitative histomorphometryRadical prostatectomyRecurrence

Identifiers

PMID28753763
PMCPMC5537035
OpenAlexW2423317702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.